Pressmeddelande -
BioGaia at ESPGHAN 2010
Probiotics in paediatrics: from evolution to clinical practice
European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN) Thursday June 10, 2010 Istanbul Convention & Exhibition Centre, Turkey
BioGaia will host a satellite symposium with the title “Probiotics in paediatrics: from evolution to clinical practice” on June 10. The symposium will present the latest clinical data on L. reuteri Protectis and the latest opinion on probiotics in paediatrics.
The Symposium is part of the 43rd Annual Meeting of the European Society for Paediatric Gastroenterology Hepatology and Nutrition (ESPGHAN). The latest opinons on the use of probiotics in paediatrics and new clinical data on Lactobacillus reuteri Protectis will be presented.
The Symposium will be chaired by Yvan Vandenplas, MD, PhD, Professor of Paediatrics, University Children’s Hospital, Brussels, Belgium.
Speakers:
Jens Walter, PhD, Assistant Professor, Department of Food Science and Technology, University of Nebraska, USA
José Saavedra, MD, PhD, Assoc. Professor of Paediatric Gastroenterology and Nutrition, Johns Hopkins University School of Medicine, USA
Francesco Savino, MD, PhD, Department of Paediatrics, Regina Margherita Hospital, University of Turin, Italy
43rd Annual Meeting of ESPGHAN
Date: Thursday June 10, 2010
Time: 07:00 – 08:30
Place: Topkapi hall, Istanbul Convention & Exhibition Centre
Program:
07:00 – 07:10 Introduction Yvan Vandenplas
07:10 – 07:30 The importance of the gastrointestinal microbiota: an evolutionary perspective Jens Walter
07:30 – 07:50 Evolution of the probiotic concept in paediatrics José Saavedra
07:50 – 08:10 Probiotics and infantile colic Francesco Savino
08:10 – 08:30 Discussion and closing remarks
Ämnen
- Medicinsk forskning
Kategorier
- probiotics
- symposium
Regioner
- Utanför Sverige
BioGaia is a innovative Swedish biotechnology company, world leader in probiotics, that develops and sells probiotic products and solutions that promote people’s health. Our products combine the well researched probiotic bacteria Lactobacillus reuteri (L. reuteri) and top of the line engineering to develop one of a kind delivery systems that match consumer needs. L. reuteri is a “good” and friendly bacterium that helps battle the “bad” micro-organisms in the digestive tract improving the host's health.
